Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 6, 2009, Pages 1904-1909

  Van Beek, Robert D ^a   Van Den Heuvel Eibrink, Marry M ^a   Hakvoort Cammel, Friederike G ^a   Van Den Bos, Cor ^b   Van Der Pal, Heleen J H ^b   Krenning, Eric P ^c   De Rijke, Yolande B ^c   Pieters, Rob ^a   De Muinck Keizer Schrama, Sabine M P F ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CALCIUM; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; PREDNISOLONE; PROCARBAZINE; THYROID HORMONE; THYROTROPIN; THYROXINE; VINBLASTINE; VINCRISTINE SULFATE;

ADOLESCENT; ADULT; ARTICLE; BODY BUILD; BODY COMPOSITION; BODY FAT; BODY GROWTH; BODY HEIGHT; BODY MASS; BONE DENSITY; CALCIUM INTAKE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHILDHOOD CANCER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; FREE THYROXINE INDEX; HODGKIN DISEASE; HUMAN; LEAN BODY WEIGHT; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; SEX DIFFERENCE; SIDE EFFECT; SITTING; SURVIVAL TIME; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL;

EID: 66749180559     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0622     Document Type: Article

References (38)

1. Gurney JG, Severson RK, Davis S, Robison LL 1995 Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 75:2186-2195
2. Hakvoort-Cammel FG, Buitendijk S, van den Heuvel-Eibrink M, Hählen K 2004 Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol. Pediatr Blood Cancer 43:8-16 (Pubitemid 38738266)
3. Schellong G 1996 Treatment of children and adolescents with Hodgkin's disease: the experience of the German-Austrian Paediatric Study Group. Baillieres Clin Haematol 9:619-634 (Pubitemid 26362749)
4. Schellong G 1998 Pediatric Hodgkin's disease: treatment in the late 1990s. Ann Oncol 9(Suppl 5):S115-S119 (Pubitemid 29049129)
5. van den Berg H, Zsiros J, Behrendt H 1997 Treatment of childhood Hodgkin's disease without radiotherapy. Ann Oncol 8(Suppl 1):15-17 (Pubitemid 27239423)
6. Holmes SJ, Whitehouse RW, Clark ST, Crowther DC, Adams JE, Shalet SM 1994 Reduced bone mineral density in men following chemotherapy for Hodgkin's disease. Br J Cancer 70:371-375 (Pubitemid 24247165)
7. Howell SJ, Berger G, Adams JE, Shalet SM 1998 Bone mineral density in women with cytotoxic-induced ovarian failure. Clin Endocrinol (Oxf) 49:397-402 (Pubitemid 28448952)
8. Kreuser ED, Felsenberg D, Behles C, Seibt-Jung H, Mielcarek M, Diehl V, Dahmen E, Thiel E 1992 Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease. Ann Oncol 3(Suppl 4):105-110
9. Ratcliffe MA, Lanham SA, Reid DM, Dawson AA 1992 Bone mineral density (BMD) in patients with lymphoma: the effects of chemotherapy, intermittent corticosteroids and premature menopause. Hematol Oncol 10:181-187
10. Redman JR, Bajorunas DR, Wong G, McDermott K, Gnecco C, Schneider R, Lacher MJ, Lane JM 1988 Bone mineralization in women following successful treatment of Hodgkin's disease. Am J Med 85:65-72 (Pubitemid 18172187)
11. Sklar C, Mertens A, Walter A, Mitchell D, Nesbit M, O'Leary M, Hutchinson R, Meadows A, Robison L 1993 Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation. J Pediatr 123:59-64 (Pubitemid 23185198)
12. van Leeuwen BL, Kamps WA, Jansen HW, Hoekstra HJ 2000 The effect of chemotherapy on the growing skeleton. Cancer Treat Rev 26:363-376
13. Roman J, Villaizán CJ, García-Foncillas J, Salvador J, Sierrasesúmaga L 1997 Growth and growth hormone secretion in children with cancer treated with chemotherapy. J Pediatr 131:105-112 (Pubitemid 27498317)
14. Boot AM, van den Heuvel-Eibrink MM, Hählen K, Krenning EP, de Muinck Keizer-Schrama SM 1999 Bone mineral density in acute lymphoblastic leukaemia. Eur J Cancer 35:1693-1697 (Pubitemid 30050642)
15. van der Sluis IM, van den Heuvel-Eibrink MM, Hählen K, Krenning EP, de Muinck Keizer-Schrama SM 2000 Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 35:415-420
16. van der Sluis IM, van den Heuvel-Eibrink MM, Hählen K, Krenning EP, de Muinck Keizer-Schrama SM 2002 Altered bone mineral density and body composition and fracture risk in childhood acute lymphoblastic leukemia. J Pediatr 141:204-210
17. Thomson AB, Wallace WH 2002 Treatment of paediatric Hodgkin's disease. A balance of risks. Eur J Cancer 38:468-477 (Pubitemid 34185385)
18. Brusamolino E, Lunghi F, Orlandi E, Astori C, Passamonti F, Baraté C, Pagnucco G, Baio A, Franchini P, Lazzarino M, Bernasconi C 2000 Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity. Haematologica 85:1032-1039
19. Soberman N, Leonidas JC, Cherrick I, Schiff R, Karayalcin G 1991 Sonographic abnormalities of the thyroid gland in longterm survivors of Hodgkin disease. Pediatr Radiol 21:250-253
20. Hancock SL, Cox RS, McDougall IR 1991 Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 325:599-605
21. Healy JC, Shafford EA, Reznek RH, Webb JA, Thomas JM, Bomanji JB, Kingston JE 1996 Sonographic abnormalities of the thyroid gland following radiotherapy in survivors of childhood Hodgkin's disease. Br J Radiol 69:617-623 (Pubitemid 26235513)
22. Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N, Greffe B, Wolden S, Robison L 2000 Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 85:3227-3232
23. Atahan IL, Yildiz F, Ozyar E, Uzal D 1998 Thyroid dysfunction in children receiving neck irradiation for Hodgkin's disease. Radiat Med 16:359-361 (Pubitemid 28549729)
24. Hudson MM, Greenwald C, Thompson E, Wilimas J, Marina N, Fairclough D, Kauffman W, Bozeman P, Mackert PW, Abromowitch M 1993 Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol 11:100-108 (Pubitemid 23059982)
25. van Santen HM, Vulsma T, Dijkgraaf MG, Blumer RM, Heinen R, Jaspers MW, Geenen MM, Offringa MO, de Vijlder JJ, van den Bos C 2003 No damaging effect of chemotherapy in addition to radiotherapy on the thyroid axis in young adult survivors of childhood cancer. J Clin Endocrinol Metab 88:3657-3663 (Pubitemid 37034510)
26. Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, Roede MJ, Verloove-Vanhorick SP, Wit JM 2000 Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res 47:316-323 (Pubitemid 30127036)
27. Kröger H, Vainio P, Nieminen J, Kotaniemi A 1995 Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology. Bone 17:157-159
28. van der Sluis IM, de Ridder MA, Boot AM, Krenning EP, de Muinck Keizer- Schrama SM 2002 Reference data for bone density and body composition measured with dual energy x-ray absorptiometry in white children and young adults. Arch Dis Child 87:341-347
29. Crabtree NJ, Shaw NJ, Boivin CM, Oldroyd B, Truscott JG 2005 Pediatric in vivo cross-calibration between the GE Lunar Prodigy and DPX-L bone densitometers. Osteoporos Int 16:2157-2167 (Pubitemid 41790939)
30. Angus RM, Sambrook PN, Pocock NA, Eisman JA 1989 A simple method for assessing calcium intake in Caucasian women. J Am Diet Assoc 89:209-214 (Pubitemid 19061840)
31. Anonymous 2000 Dietary reference values: calcium, vitamin D, thiamin, riboflavin, niacin, pantothenic acid, and biotin. In: The Hague, The Netherlands: Health Council of the Netherlands
32. van Beek RD, de Muinck Keizer-Schrama SM, Hakvoort-Cammel FG, van der Sluis IM, Krenning EP, Pieters R, van den Heuvel-Eibrink MM 2006 No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 46:88-93 (Pubitemid 41779323)
33. Drop SJS, Visser HKA 1989 Geslachtsdifferentiatie, groei en puberteit. In: Henneman G ed. Endocrinologie. 2nd ed. Utrecht, The Netherlands: Bunge 275-311
34. Willman KY, Cox RS, Donaldson SS 1994 Radiation induced height impairment in pediatric Hodgkin's disease. Int J Radiat Oncol Biol Phys 28:85-92 (Pubitemid 24012858)
35. Papadakis V, Tan C, Heller G, Sklar C 1996 Growth and final height after treatment for childhood Hodgkin disease. J Pediatr Hematol Oncol 18:272-276 (Pubitemid 26249500)
36. van Beek RD, van den Heuvel-Eibrink MM, Laven JS, de Jong FH, Themmen AP, Hakvoort-Cammel FG, van den Bos C, van den Berg H, Pieters R, de Muinck Keizer-Schrama SM 2007 Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J Clin Endocrinol Metab 92:3869-3874 (Pubitemid 47607635)
37. Nysom K, Holm K, Michaelsen KF, Hertz H, Müller J, Mølgaard C 2003 Degree of fatness after treatment of malignant lymphoma in childhood. Med Pediatr Oncol 40:239-243 (Pubitemid 36222830)
38. van Beek RD, Smit M, van den Heuvel-Eibrink MM, de Jong FH, Hakvoort- Cammel FG, van den Bos C, van den Berg H, Weber RF, Pieters R, de Muinck Keizer-Schrama SM 2007 Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood. Hum Reprod 22:3215-3222